Cargando…

The Clinical Significance of Unknown Sequence Variants in BRCA Genes

Germline mutations in BRCA1/2 genes are responsible for a large proportion of hereditary breast and/or ovarian cancers. Many highly penetrant predisposition alleles have been identified and include frameshift or nonsense mutations that lead to the translation of a truncated protein. Other alleles co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calò, Valentina, Bruno, Loredana, Paglia, Laura La, Perez, Marco, Margarese, Naomi, Gaudio, Francesca Di, Russo, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837329/ https://www.ncbi.nlm.nih.gov/pubmed/24281179 http://dx.doi.org/10.3390/cancers2031644

Ejemplares similares

Clinical significance of variants of unknown significances in BRCA genes
por: Choi, Min Chul
Publicado: (2019)

High-throughput functional evaluation of BRCA2 variants of unknown significance
por: Ikegami, Masachika, et al.
Publicado: (2020)

The influence of BRCA variants of unknown significance on cancer risk management decision-making
por: Chern, Jing-Yi, et al.
Publicado: (2019)

Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
por: Fanale, Daniele, et al.
Publicado: (2021)

Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine
por: De Paolis, Elisa, et al.
Publicado: (2023)

Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance
por: Langerud, Jonas, et al.
Publicado: (2018)

Reclassification of Five BRCA1/2 Variants with Unknown Significance Using Complex Functional Study
por: Bozsik, Anikó, et al.
Publicado: (2022)

From a variant of unknown significance to pathogenic: Reclassification of a large novel duplication in BRCA2 by high‐throughput sequencing
por: van Luttikhuizen, Jana Lisa, et al.
Publicado: (2019)

Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
por: Kim, Joo Heung, et al.
Publicado: (2021)

Predicting Ovarian/Breast Cancer Pathogenic Risks of Human BRCA1 Gene Variants of Unknown Significance
por: Lin, Hui-Heng, et al.
Publicado: (2021)

BRCA1 and BRCA2 Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants
por: Concolino, Paola, et al.
Publicado: (2019)

Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells
por: Insalaco, Lavinia, et al.
Publicado: (2012)

Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea
por: Seo, Jun Hyeong, et al.
Publicado: (2019)

Author Correction: Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
por: Kim, Joo Heung, et al.
Publicado: (2023)

Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India
por: Mehta, Anurag, et al.
Publicado: (2018)

The functional impact of variants of uncertain significance in BRCA2
por: Mesman, Romy L. S., et al.
Publicado: (2018)

Removing uncertainty from variants of unknown significance
por: McNally, Elizabeth M.
Publicado: (2023)

Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients
por: Eoh, Kyung Jin, et al.
Publicado: (2017)

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance
por: Iversen, Edwin S., et al.
Publicado: (2022)

Next-Generation Sequencing in Order to Better Characterize a BRCA Variant of Uncertain Significance
por: Sorscher, Steven, et al.
Publicado: (2017)

Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes
por: Incorvaia, Lorena, et al.
Publicado: (2020)

Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes
por: Mazzaccara, Cristina, et al.
Publicado: (2022)

Are DDX41 variants of unknown significance and pathogenic variants created equal?
por: Xie, Zhuoer, et al.
Publicado: (2023)

Missense Variants of Uncertain Significance (VUS) Altering the Phosphorylation Patterns of BRCA1 and BRCA2
por: Tram, Eric, et al.
Publicado: (2013)

BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients
por: Incorvaia, Lorena, et al.
Publicado: (2020)

Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance
por: van Lint, F. H. M., et al.
Publicado: (2019)

Computational and experimental methods for classifying variants of unknown clinical significance
por: Spielmann, Malte, et al.
Publicado: (2022)

Actionability classification of variants of unknown significance correlates with functional effect
por: Johnson, Amber, et al.
Publicado: (2023)

Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2
por: Fanale, Daniele, et al.
Publicado: (2020)

Somatic variants of potential clinical significance in the tumors of BRCA phenocopies
por: Buckingham, Lela, et al.
Publicado: (2019)

The known unknown: the challenges of genetic variants of uncertain significance in clinical practice
por: Hoffman-Andrews, Lily
Publicado: (2018)

Characterizing variants of unknown significance in rhodopsin: A functional genomics approach
por: Wan, Aliete, et al.
Publicado: (2019)

Hereditary variants of unknown significance in African American women with breast cancer
por: McDonald, J. Tyson, et al.
Publicado: (2022)

Classifying Variants of Undetermined Significance in BRCA2 with Protein Likelihood Ratios
por: Karchin, Rachel, et al.
Publicado: (2008)

Clinically Significant Unclassified Variants in BRCA1 and BRCA2 genes among Korean Breast Cancer Patients
por: Yoon, Kyong-Ah, et al.
Publicado: (2017)

Novel variants of unknown significance in the PMS2 gene identified in patients with hereditary colon cancer
por: Liccardo, Raffaella, et al.
Publicado: (2019)

Problems of Unknown Significance: Counseling in The Era of Next Generation Sequencing
por: Fahrioğlu, U
Publicado: (2018)

Hereditary breast cancer – a spectrum of pathogenic mutations and unknown variants of BRCA1 and BRCA2 genes in the Czech Republic: efficiency of testing and clinical follow-up
por: Foretova, L, et al.
Publicado: (2005)

The Caveolin‐3 G56S sequence variant of unknown significance: Muscle biopsy findings and functional cell biological analysis
por: Brauers, Eva, et al.
Publicado: (2016)

A functional assay to classify ZBTB24 missense variants of unknown significance
por: Wu, Haoyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_caeu03ajvnn4g77eev93snm121